Search
for
Sort by
Research 811–840 of 1000+
- Balding by 25: 5 Real Reasons Indian Men Are Losing Hair Decades Early (It's Not Just Genes)
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Role of 5α-reductase inhibitors in Parkinson's disease: Gambling or not?
- Pharmacological inhibition of 5α-reductase in androgenetic alopecia: a comparative narrative review of finasteride and dutasteride, with attention to responder heterogeneity and female pattern hair loss
- Pharmacological inhibition of 5α-reductase in androgenetic alopecia: a comparative narrative review of finasteride and dutasteride, with attention to responder heterogeneity and female pattern hair loss
- Inibição seletiva da 5α-redutase e preservação da aromatase no transplante capilar
- Topical 4‐Aminopyridine 5% in Male Androgenetic Alopecia: A Split‐Scalp Exploratory Series
- Efficacy and safety of topical 5% minoxidil in treatment of androgenetic alopecia
- The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study
- Identification of Metabolites for the Novel 5α‐Reductase Inhibitor Epristeride In Vitro and Its Potential Impact on Doping Testing
- Hyaluronic acid microneedles enhance transdermal delivery of minoxidil derivatives with 1,2,4-oxadiazole-5-one unit for effective hair regeneration: Insights from X-ray crystallography and animal models
- Finasteride and the 5-Alpha Reductase Inhibitors
- 7DHC and BM15766 treated mice (C57BL/6; n = 5) failed to regrow the hairs.
- Microneedling kombinasi minoksidil 5% dengan steroid sistemik dan topikal pada pasien alopesia areata: laporan kasus
- 0192 Estrogenic effects of 5-alpha-reductase inhibitors in male androgenetic alopecia patients
- Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals
- Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open‐Label Single‐Arm Clinical Trial
- comparative study between minoxidil 5% and micro-botulinum toxin effectiveness in treatment of female pattern androgenetic alopecia with dermoscopic evaluation
- Oral minoxidil 2.5 mg versus 5 mg for treatment of male androgenetic alopecia: a double-blind randomized clinical trial
- Efficiency of 5% Minoxidil and Platelet-rich Plasma Therapy in Androgenetic Alopecia - A Retrospective Study
- Oral Finasteride (5 mg and 2 mg) versus Topical Minoxidil 5% in Female Pattern Hair Loss
- Efficacy and safety of combined fractional photothermolysis and topical minoxidil 5% versus topical minoxidil 5% alone in the treatment of male pattern hair loss: a systematic review and meta-analysis
- Efficacy of 5% Minoxidil Versus Platelet Rich Plasma in Treatment of Alopecia Areata
- Sublingual Minoxidil 5 mg versus Oral Minoxidil 5 mg for male androgenetic alopecia: A double‐blind randomized clinical trial
- Platelet-rich plasma and topical minoxidil 5% in the treatment of severe alopecia areata: Report of two cases
- Comparison between Topical Minoxidil 5% Alone versus Combined with Dutasteride (Topical 0.02% through Microneedling or Oral 0.5 mg) in Treatment of Androgenetic Alopecia
- In vitro 5α-reductase inhibition by selected Ayurvedic herbs for androgenic disorders
- The use of 5 alpha-reductase in the era of minimally invasive surgical therapies (MISTs): Is it still valuable?
- Split-scalp pilot study to evaluate effectiveness of Minoxidil 0,5% MMP® versus Topical Minoxidil 5% in the treatment of Female Pattern Hair Loss
- Oral minoxidil 7.5 mg for hair loss increases heart rate with no change in blood pressure in 24 h Holter and 24 h ambulatory blood pressure monitoring